Form 4 for MBRX Moleculin Biotech, Inc.
Accepted 2023-12-27 00:00:00 ET · period of report 2023-12-26 · accession 0001437749-23-035340 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-12-27 | 2023-12-26 | MBRX | KLEMP WALTER V | CEO, Pres, Dir | P - Purchase | $0.69 | +188.4K | 680.9K | +38% | +$130.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-12-26 | P | A | 188,404 | $0.69 | 680,880 | D | — | — |